Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1637 1652 1656
This examiner grants 68% of resolved cases
Hope A. Robinson, working in Tech Center 1600 and Art Unit 1637, has a portfolio of 1056 resolved cases. The allowance rate for this examiner is 67.7 percent, reflecting the probability of obtaining a patent. Prosecution here involves a median days to allowance of 1213, which is a duration for applications in the biotechnology or chemical sectors. This timeline requires practitioners to manage client expectations regarding the speed of the examination process and the potential for multiple rounds of rejection.
The interview lift of 43.1 percent is a data point for strategic planning. This suggests that while the base allowance rate is 67.7 percent, the probability of success increases when an interview is conducted. For practitioners in Art Unit 1637, scheduling an interview appears to be a tactical move to mitigate the 1213-day median wait and improve the overall odds of a favorable outcome. With 1056 resolved cases providing a data set, the interview lift indicates that direct communication is effective. This strategy is useful for navigating the complexities of Tech Center 1600 with this examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18262318 | METHOD FOR SIZE BASED EVALUATION OF PANCREATIC PROTEIN MIXTURE | Final Rejection | Kashiv BioSciences, LLC |
| 18632426 | USE OF BIOMARKERS TO DETERMINE WHETHER A SUBJECT HAS SUSTAINED, MAY HAVE SUSTAINED OR IS SUSPECTED OF SUSTAINING A SUBACUTE ACQUIRED BRAIN INJURY (ABI) | Non-Final OA | Abbott Laboratories |
| 18534843 | ARGININE WASH IN PROTEIN PURIFICATION | Non-Final OA | H. LUNDBECK A/S |
| 18787311 | METHODS FOR ENGINEERING OUTER MEMBRANE VESICLE PRODUCTION AND CARGO PACKAGING IN PSEUDOMONAS PUTIDA | Non-Final OA | Alliance for Energy Innovation, LLC |
| 18005086 | POLYNUCLEOTIDE ENCODING AN AMINO ACID SEQUENCE, ENCODING AN OXIDOREDUCTASE | Final Rejection | Evonik Operations GmbH |
| 18867974 | NUCLEIC ACID MODIFIED TO OBTAIN ENHANCED ERGOTHIONEINE PRODUCTIVITY, AND MICROORGANISM HAVING GENETIC MODIFICATION | Non-Final OA | KIKKOMAN CORPORATION |
| 18863705 | GENETICALLY MODIFIED YEAST AND FERMENTATION PROCESSES FOR THE PRODUCTION OF ARABITOL | Non-Final OA | Cargill, Incorporated |
| 18698789 | KYNURENINE AMINOTRANSFERASE AND PRODUCTS THEREOF FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES | Final Rejection | UNIVERSITE PARIS-SACLAY |
| 18266282 | LYSOSOMAL ACID LIPASE VARIANTS AND USES THEREOF | Final Rejection | UNIVERSITE PARIS-SACLAY |
| 18871339 | MEANS AND METHODS FOR REDUCING PHOSPHORUS SECRETION BY FISH | Non-Final OA | NOVOZYMES A/S |
| 18857409 | PROCESS FOR PRODUCING FREE FATTY ACIDS | Non-Final OA | Novozymes A/S |
| 18765528 | CONVENIENT SYNTHESIS OF GLUCOSONE BY WHOLE-CELL CATALYSIS UNDER OXYGEN | Non-Final OA | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE |
| 17916441 | ADAMTS13 VARIANT, COMPOSITIONS, AND USES THEREOF | Non-Final OA | TAKEDA PHARMACEUTICAL COMPANY LIMITED |
| 18683749 | POLYNUCLEOTIDES ENCODING NOVEL NUCLEASES, COMPOSITIONS THEREOF AND METHODS THEREOF FOR ELIMINATING DNA FROM PROTEIN PREPARATIONS | Non-Final OA | DANISCO US INC. |
| 17623086 | MODIFIED YEAST CELLS THAT OVER-EXPRESS SELECTED ENDOGENOUS PROTEINS | Final Rejection | DANISCO US INC |
| 18720533 | PRODUCTION OF ALPHA-1,4-FUCOSYLATED COMPOUNDS | Non-Final OA | INBIOSE N.V. |
| 18167687 | PRODUCTION OF GALACTOSYLATED DI- AND OLIGOSACCHARIDES | Non-Final OA | INBIOSE N.V. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy